Health and Human Services News and Research

RSS

US officials want to end the HIV epidemic by 2030. Many stakeholders think they won’t.

In 2018, Mike Ferraro was living on the street and sharing needles with other people who injected drugs when he found out he was HIV-positive.

24 Apr 2023

Most kids recover from Lyme disease within six months of completing antibiotic treatment

A majority of parents of children diagnosed with Lyme disease reported that their kids recovered within six months of completing antibiotic treatment, according to a new joint study from Children's National Research Institute and the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, published in Pediatric Research.

21 Apr 2023

The Biden administration vowed to be a leading voice on opioid settlements but has gone quiet

Early in President Joe Biden's tenure, his administration promised to play a key role in ensuring opioid settlement funds went toward tackling the nation's addiction crisis.

21 Apr 2023

VA and NIH launch new study to better understand chronic symptoms of Gulf War Illness

The Department of Veterans Affairs (VA) and National Institutes of Health have launched a study to gain a better understanding of the chronic symptoms of Gulf War Illness.

17 Apr 2023

Healthy People 2030 target is achievable with modest reductions in added sugars intake

Reducing caloric intake from added sugars is a Leading Health Indicator in Healthy People 2030, a national public health initiative led by the US Department of Health and Human Services that sets data-driven national objectives to improve health and wellbeing over the next decade.

13 Apr 2023

Bivalent COVID-19 boosters provide durable, effective protection against omicron subvariants

New research led by the UNC Gillings School of Global Public Health shows that bivalent COVID-19 boosters are still providing effective protection from hospitalization and death, even against the most recent omicron subvariants.

13 Apr 2023

The importance and challenges of developing mucosal SARS-COV-2 vaccines

In November 2022, the National Institute of Allergy and Infectious Diseases co-hosted a virtual workshop on the importance and challenges of developing mucosal vaccines for SARS-COV-2.

13 Apr 2023

Pragmatica-Lung Study aims to increase accessibility to cancer clinical trials

The National Cancer Institute, part of the National Institutes of Health (NIH), has helped launch a phase 3 randomized clinical trial (NCT05633602) of a two-drug combination to treat patients with advanced non-small cell lung cancer (NSCLC).

12 Apr 2023

Daily statin medication could improve cardiovascular outcomes in people with HIV

A National Institutes of Health clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV in the first large-scale clinical study to test a primary cardiovascular prevention strategy in this population.

11 Apr 2023

No-cost preventive services are now in jeopardy. Here’s what you need to know.

When a federal judge in Texas declared unconstitutional a popular part of the Affordable Care Act that ensures no-cost preventive care for certain services, such as screening exams for conditions such as diabetes, hepatitis, and certain cancers, it left a lot of people with a lot of questions.

7 Apr 2023

Post-exposure doxycycline approach leads to two-thirds reduction in STI incidence

The oral antibiotic doxycycline prevented the acquisition of sexually transmitted infections (STIs) when tested among men who have sex with men (MSM) and transgender women who took the medication within 72 hours of having condomless sex, according to findings published today in the New England Journal of Medicine.

6 Apr 2023

The ‘unwinding’ of Medicaid

Several states have begun the herculean task of redetermining how many of an estimated 85 million Americans currently receiving health coverage through the Medicaid program are still eligible.

6 Apr 2023

Study identifies disparities among patients receiving advanced pulmonary support

Some adults with severe respiratory illness, including women, those with public insurance, and people with fewer financial resources, may be less likely to receive an advanced form of life support known as extracorporeal membrane oxygenation (ECMO).

6 Apr 2023

New treatment for fibrous dysplasia shows promising results in NIH clinical trial

A clinical trial at the National Institutes of Health found that a medication, denosumab, significantly reduced abnormal bone turnover in adults with fibrous dysplasia, a rare disease marked by weak and misshapen bones.

4 Apr 2023

Novel immunotherapy-based approach for low-grade lymphomatoid granulomatosis improves patient survival

Results from a clinical trial conducted by researchers at the National Institutes of Health (NIH) show that people with low-grade lymphomatoid granulomatosis who are treated with interferon alfa-2b, a type of immunotherapy, can live for decades after diagnosis.

4 Apr 2023

Membrane attack complex could be a potential therapeutic target to slow or prevent AMD

A study from the National Eye Institute (NEI) identified rare genetic variants that could point to one of the general mechanisms driving age-related macular degeneration (AMD), a common cause of vision loss in older adults.

3 Apr 2023

Buprenorphine can be safely started in the ER without triggering withdrawal even for people using stronger opioids

Results from a multi-site clinical trial supported by the National Institutes of Health showed that less than 1% of people with opioid use disorder whose drug use includes fentanyl experienced withdrawal when starting buprenorphine in the emergency department.

30 Mar 2023

$50 billion in opioid settlement cash is on the way. We’re tracking how it’s spent.

More than $50 billion in settlement funds is being delivered to thousands of state and local governments from companies accused of flooding their communities with opioid painkillers that have left millions addicted or dead.

30 Mar 2023

Study shows benefits of expanding the use of telehealth services for people with opioid use disorder

The expanded availability of opioid use disorder-related telehealth services and medications during the COVID-19 pandemic was associated with a lowered likelihood of fatal drug overdose among Medicare beneficiaries, according to a new study.

29 Mar 2023

FDA-approved drug keeps light-sensitive photoreceptors alive in lab models of LCA 10

A National Institutes of Health team has identified a compound already approved by the U.S. Food and Drug Administration that keeps light-sensitive photoreceptors alive in three models of Leber congenital amaurosis type 10 (LCA 10), an inherited retinal ciliopathy disease that often results in severe visual impairment or blindness in early childhood.

29 Mar 2023

Health and Human Services News and Research

US officials want to end the HIV epidemic by 2030. Many stakeholders think they won’t.

Most kids recover from Lyme disease within six months of completing antibiotic treatment

The Biden administration vowed to be a leading voice on opioid settlements but has gone quiet

VA and NIH launch new study to better understand chronic symptoms of Gulf War Illness

Healthy People 2030 target is achievable with modest reductions in added sugars intake

Bivalent COVID-19 boosters provide durable, effective protection against omicron subvariants

The importance and challenges of developing mucosal SARS-COV-2 vaccines

Pragmatica-Lung Study aims to increase accessibility to cancer clinical trials

Daily statin medication could improve cardiovascular outcomes in people with HIV

No-cost preventive services are now in jeopardy. Here’s what you need to know.

Post-exposure doxycycline approach leads to two-thirds reduction in STI incidence

The ‘unwinding’ of Medicaid

Study identifies disparities among patients receiving advanced pulmonary support

New treatment for fibrous dysplasia shows promising results in NIH clinical trial

Novel immunotherapy-based approach for low-grade lymphomatoid granulomatosis improves patient survival

Membrane attack complex could be a potential therapeutic target to slow or prevent AMD

Buprenorphine can be safely started in the ER without triggering withdrawal even for people using stronger opioids

$50 billion in opioid settlement cash is on the way. We’re tracking how it’s spent.

Study shows benefits of expanding the use of telehealth services for people with opioid use disorder

FDA-approved drug keeps light-sensitive photoreceptors alive in lab models of LCA 10

Event guide: 6th Operationalize Expanded Access Programs Summit East eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News